Ren Xingjie, Wang Mengchi, Li Bingkun, Jamieson Kirsty, Zheng Lina, Jones Ian R, Li Bin, Takagi Maya Asami, Lee Jerry, Maliskova Lenka, Tam Tsz Wai, Yu Miao, Hu Rong, Lee Lindsay, Abnousi Armen, Li Gang, Li Yun, Hu Ming, Ren Bing, Wang Wei, Shen Yin
Institute for Human Genetics, University of California, San Francisco, San Francisco, CA, USA.
Bioinformatics and Systems Biology Graduate Program, University of California, San Diego, La Jolla, CA, USA.
Sci Adv. 2021 Sep 17;7(38):eabi4360. doi: 10.1126/sciadv.abi4360. Epub 2021 Sep 15.
Current pooled CRISPR screens for cis-regulatory elements (CREs), based on transcriptional output changes, are typically limited to characterizing CREs of only one gene. Here, we describe CRISPRpath, a scalable screening strategy for parallelly characterizing CREs of genes linked to the same biological pathway and converging phenotypes. We demonstrate the ability of CRISPRpath for simultaneously identifying functional enhancers of six genes in the 6-thioguanine–induced DNA mismatch repair pathway using both CRISPR interference (CRISPRi) and CRISPR nuclease (CRISPRn) approaches. Sixty percent of the identified enhancers are known promoters with distinct epigenomic features compared to other active promoters, including increased chromatin accessibility and interactivity. Furthermore, by imposing different levels of selection pressure, CRISPRpath can distinguish enhancers exerting strong impact on gene expression from those exerting weak impact. Our results offer a nuanced view of cis-regulation and demonstrate that CRISPRpath can be leveraged for understanding the complex gene regulatory program beyond transcriptional output at scale.
目前基于转录输出变化对顺式调控元件(CREs)进行的CRISPR筛选池,通常仅限于对单个基因的CREs进行表征。在此,我们描述了CRISPRpath,这是一种可扩展的筛选策略,用于并行表征与同一生物途径和趋同表型相关的基因的CREs。我们展示了CRISPRpath使用CRISPR干扰(CRISPRi)和CRISPR核酸酶(CRISPRn)方法同时鉴定6-硫鸟嘌呤诱导的DNA错配修复途径中六个基因的功能增强子的能力。与其他活性启动子相比,60%的已鉴定增强子是具有独特表观基因组特征的已知启动子,包括染色质可及性和相互作用增加。此外,通过施加不同水平的选择压力,CRISPRpath可以区分对基因表达有强烈影响的增强子和影响较弱的增强子。我们的结果提供了对顺式调控的细致见解,并证明CRISPRpath可用于大规模理解超越转录输出的复杂基因调控程序。